Concepedia

Shannon Armstrong

SA

Statistics

Publications

7

Citations

297

H-Index

7

Active since

2013

Affiliations

GfK (United States)(Current)

Boston Scientific (United States)

Mount Sinai Medical Center

Doctors Company (United States)

University of Sheffield

Shannon Armstrong is an author at GfK (United States) specializing in cost-effectiveness analysis, medicine, and pharmacoeconomics.

Publications per year

2013–2018

7

Publications

7

Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF

Vivek Y. Reddy, R. Akehurst, Shannon Armstrong et al. · Journal of the American College of Cardiology · 2015 · 97 citations

, , +11

Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin

Vivek Y. Reddy, R. Akehurst, Shannon Armstrong et al. · EP Europace · 2016 · 51 citations · Full text

, , +17

Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation

Sandeep Panikker, Joanne Lord, Julian W.E. Jarman et al. · European Heart Journal · 2016 · 48 citations · Full text

, , +15

The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation.

Susan Garfield, Meghan Gavaghan, Shannon Armstrong et al. · PubMed · 2013 · 44 citations

, , +13

Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials

Thomas P. Lodise, Mark Redell, Shannon Armstrong et al. · Open Forum Infectious Diseases · 2017 · 25 citations · Full text

, , +13

1–5 of 7